{"id":5447,"date":"2024-10-17T14:35:43","date_gmt":"2024-10-17T13:35:43","guid":{"rendered":"https:\/\/event.eortc.org\/qol-conference-2025\/?page_id=5447"},"modified":"2025-05-05T12:49:05","modified_gmt":"2025-05-05T11:49:05","slug":"programme","status":"publish","type":"page","link":"https:\/\/event.eortc.org\/qol-conference-2025\/programme\/","title":{"rendered":"Programme"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background fusion-parallax-none nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:6%;--awb-padding-bottom:2%;--awb-padding-top-medium:240px;--awb-padding-top-small:240px;--awb-background-image:url(&quot;https:\/\/event.eortc.org\/qol-conference-2025\/wp-content\/uploads\/sites\/29\/2022\/12\/qol_gradient_background_2560x1440_2022.png&quot;);--awb-background-size:cover;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-center fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column fusion-flex-align-self-center\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-center fusion-content-layout-row fusion-flex-align-items-center\"><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-one\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;\"><h1 class=\"fusion-title-heading title-heading-center\" style=\"margin:0;\">Programme<\/h1><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-margin-top:4%;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-tabs fusion-tabs-1 classic nav-is-justified awb-tabs-transition awb-tabs-transition-fade awb-tabs-title-radius horizontal-tabs icon-position-right mobile-mode-accordion\" style=\"--icon-color:var(--awb-custom_color_2);--awb-title-border-radius-top-left:23px;--awb-title-border-radius-top-right:23px;--awb-title-border-radius-bottom-right:20px;--awb-title-border-radius-bottom-left:20px;--awb-content-padding-top:0px;--awb-content-padding-right:0px;--awb-content-padding-bottom:0px;--awb-content-padding-left:0px;--awb-alignment:start;--awb-inactive-color:#1f2f98;--awb-title-text-color:var(--awb-custom_color_2);--awb-title-active-text-color:#1f2f98;--awb-background-color:#c9ddff;--awb-border-color:rgba(120,127,246,0);--awb-active-border-color:var(--awb-color4);--awb-active-border-size:3px;--awb-transition-speed:300ms;--awb-border-size:1px;\"><div class=\"nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\" aria-orientation=\"horizontal\"><li class=\"active\" role=\"presentation\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-c041604ce461ddf9fa7\" aria-selected=\"true\" tabindex=\"0\" id=\"fusion-tab-c041604ce461ddf9fa7\" href=\"#tab-c041604ce461ddf9fa7\"><h3 class=\"fusion-tab-heading\">Monday, 12 May 2025<\/h3><\/a><\/li><li  role=\"presentation\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-457bf181febd6969740\" aria-selected=\"false\" tabindex=\"-1\" id=\"fusion-tab-457bf181febd6969740\" href=\"#tab-457bf181febd6969740\"><h3 class=\"fusion-tab-heading\">Tuesday, 13 May 2025<\/h3><\/a><\/li><\/ul><\/div><div class=\"tab-content\"><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\" aria-orientation=\"horizontal\"><li class=\"active\" role=\"presentation\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-c041604ce461ddf9fa7\" aria-selected=\"true\" tabindex=\"0\" id=\"mobile-fusion-tab-c041604ce461ddf9fa7\" href=\"#tab-c041604ce461ddf9fa7\"><h3 class=\"fusion-tab-heading\">Monday, 12 May 2025<\/h3><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix in active\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-c041604ce461ddf9fa7\" id=\"tab-c041604ce461ddf9fa7\"><div class=\"awb-tab-pane-inner\">\n<table style=\"background-color: #fff;\" border=\"1\" width=\"100%\" cellpadding=\"10\">\n<tbody>\n<tr>\n<td style=\"background-color: #f6f6f6;\" width=\"25\">08:00 &#8211; 09:00<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Welcome coffee and registration<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 1. Introduction to patient-reported outcomes (PROs) and health-related quality of life (HRQOL) in cancer clinical research<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#07a52895d90ce8a89\">Madeline Pe<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#0ec44a1709b459b22\">Dagmara Kuli\u015b<\/a><\/td>\n<\/tr>\n<tr>\n<td>9:00 \u2013 9:15<\/td>\n<td>Welcome and meeting objectives<\/td>\n<\/tr>\n<tr>\n<td>9:15 \u2013 9:30<\/td>\n<td>Importance of PROs from the patient community perspective &#8211; myths and reality of PRO use <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#4431d0d000eb36f93\">Jan Geissler<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"30%\">9:30 \u2013 9:45<\/td>\n<td>Using PROs in clinical trials and practice <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#53d39c75e18ae9eeb\">Alexandra Gilbert<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>9:45 \u2013 10:00<\/td>\n<td>Evaluating HRQOL in cancer clinical trials: The EORTC measurement strategy <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#cca15a2cf03928889\">Mogens Groenvold<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 2. EORTC and ESMO Special Session (ESMO-MCBS)<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#50fe46a3a66e74b6b\">Katarzyna Pogoda<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#646f196ca8ec78d96\">Sjoukje Oosting<\/a><\/td>\n<\/tr>\n<tr>\n<td>10:00 \u2013 10:10<\/td>\n<td>Introduction of session by Chairs<\/td>\n<\/tr>\n<tr>\n<td>10:10 \u2013 10:30<\/td>\n<td>Why HRQOL is a critical component in the assessment of clinical benefit: The ESMO-MCBS <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#646f196ca8ec78d96\">Sjoukje Oosting<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>10:30 \u2013 10:45<\/td>\n<td>Case study: HRQOL endpoint in a breast cancer trial <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#50fe46a3a66e74b6b\">Katarzyna Pogoda<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>10:45 \u2013 11:00<\/td>\n<td>HRQOL benefit in de-escalation trials: Experience from cancer clinical trials in India <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#995812a12c6420fa4\">Priya Ranganathan<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>11:00 \u2013 11:15<\/td>\n<td>The importance of QoL for measuring patient benefit <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#01b8e9ea8bc786402\">Ananda Plate<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">11:15 \u2013 11:45<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Coffee break<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 3. Current developments in EORTC measurement tools and their use in cancer clinical research<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#b05fdb6d087b07678\">Sally Wheelwright<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#a1297ed48da38850b\">Johannes Giesinger<\/a><\/td>\n<\/tr>\n<tr>\n<td>11:45 \u2013 11:55<\/td>\n<td>Introduction of session by Chairs<\/td>\n<\/tr>\n<tr>\n<td>11:55 \u2013 12:10<\/td>\n<td>Measuring HRQOL core outcomes and disease-specific symptoms: The EORTC QLQ-C30 and its modules <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#0ca838bac5080b225\">Samantha Sodergren<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#747a64b72e5c20814\">Francesca Martinelli<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>12:10 \u2013 12:25<\/td>\n<td>Developing study-specific item lists with the EORTC Item Library <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#5874f78e328e65c08\">Claire Piccinin<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>12:25 \u2013 12:40<\/td>\n<td>Personalised assessment of HRQOL: EORTC computer adaptive testing tools <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#5b9535b597302820d\">Hugo Vachon<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>12:40 \u2013 12:55<\/td>\n<td>Health utility assessment with the QLQ-C30: The QLU-C10D <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#2951b03ff68ea0795\">Eva Gamper<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>12:55 \u2013 13:10<\/td>\n<td>Addressing missing patient-specific HRQOL issues in questionnaires: The WISP (Write-In three Symptoms\/Problems) Instrument <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#5874f78e328e65c08\">Claire Piccinin<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>13:10 \u2013 13:25<\/td>\n<td>Development and translation of linguistically and culturally validated questionnaires <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#0ec44a1709b459b22\">Dagmara Kuli\u015b<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">13:25 \u2013 14:45<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Lunch break<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 4. Considerations in the assessment of PROs for special cancer patient populations &#8211; \u201dunmet needs\u201d<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#01b8e9ea8bc786402\">Ananda Plate<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#cca15a2cf03928889\">Mogens Groenvold<\/a><\/td>\n<\/tr>\n<tr>\n<td>14:45 \u2013 14:55<\/td>\n<td>Introduction of session by Chairs<\/td>\n<\/tr>\n<tr>\n<td>14:55 \u2013 15:10<\/td>\n<td>Benefits and challenges of PRO assessment in children with cancer <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#4a29aa5437fec84b5\">David Riedl<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>15:10 \u2013 15:25<\/td>\n<td>Quality of life of adolescents and young adults with cancer <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#6e25725475bb40ba8\">Anne-Sophie Darlington<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>15:25 \u2013 15:40<\/td>\n<td>Rare cancers <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#31b63d054ecd97a6d\">Olga Husson<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>15:40 \u2013 15:55<\/td>\n<td>Cognitively impaired patients <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#2299c6fea674c1a96\">Jaap Reijneveld<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>15:55 \u2013 16:10<\/td>\n<td>Older adults <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#15b758da085fea3b3\">Paolo Bossi<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>16:10 \u2013 16:25<\/td>\n<td>Palliative care <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#cca15a2cf03928889\">Mogens Groenvold<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">16:25 &#8211; 16:55<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Coffee break<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 5. What is a clinically relevant PRO score? Development and methodological considerations<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#16fd4117a403bcd80\">Jammbe Musoro<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#800bc73157e8be809\">Antoine Regnault<\/a><\/td>\n<\/tr>\n<tr>\n<td>16:55 \u2013 17:05<\/td>\n<td>Introduction of session by Chairs<\/td>\n<\/tr>\n<tr>\n<td>17:05 \u2013 17:20<\/td>\n<td>Going beyond statistical significance: Is the difference clinically relevant? <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#16fd4117a403bcd80\">Jammbe Musoro<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>17:20 \u2013 17:35<\/td>\n<td>Interpreting individual patients\u2019 scores: Determining whether a patient improved or worsened in their HRQOL <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#a1297ed48da38850b\">Johannes Giesinger<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>17:35 \u2013 17:50<\/td>\n<td>The need for reference values and general population norm data for PRO measures <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#50abb80fb8d8f6b78\">Monika Sztankay<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">17:50 \u2013 18:00<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Summary and end of the day<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">18:00 \u2013 19:00<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Evening cocktail<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\" aria-orientation=\"horizontal\"><li  role=\"presentation\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-457bf181febd6969740\" aria-selected=\"false\" tabindex=\"-1\" id=\"mobile-fusion-tab-457bf181febd6969740\" href=\"#tab-457bf181febd6969740\"><h3 class=\"fusion-tab-heading\">Tuesday, 13 May 2025<\/h3><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-457bf181febd6969740\" id=\"tab-457bf181febd6969740\"><div class=\"awb-tab-pane-inner\">\n<table style=\"background-color: #fff;\" border=\"1\" width=\"100%\" cellpadding=\"10\">\n<tbody>\n<tr>\n<td style=\"background-color: #f6f6f6;\" width=\"25\">08:00 &#8211; 09:00<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Welcome coffee<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 6. Use of PROs in regulatory and HTA decision-making<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#4431d0d000eb36f93\">Jan Geissler<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#91bfd395e3864caca\">Sigrid Klaar<\/a><\/td>\n<\/tr>\n<tr>\n<td>9:00 \u2013 9:10<\/td>\n<td>Introduction of session by Chairs<\/td>\n<\/tr>\n<tr>\n<td>9:10 \u2013 9:25<\/td>\n<td>Overview of the role of PROs\/HRQOL in the regulatory and HTA framework <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#1d9df8d984231072b\">Anja Schiel<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"30%\">9:25 \u2013 9:40<\/td>\n<td>EU regulatory views on the generation and use of patient experience data <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#6cbb5b09c5f66e073\">Juan Garc\u00eda Burgos<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>9:40 \u2013 9:55<\/td>\n<td>Role of PROs\/HRQOL in HTA evaluations <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#e1647cd6890e0e114\">Kirsten Janke<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>9:55 \u2013 10:10<\/td>\n<td>Use of HRQOL in economic evaluations <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#bd7afb123d7f5df43\">Jan Liliemark<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>10:10 \u2013 10:25<\/td>\n<td>Industry views on the use of PROs in regulatory and HTA decision-making <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#91bfd395e3864caca\">Sigrid Klaar<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">10:25 \u2013 11:00<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Coffee break<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 7. Statistical considerations in the use of PROs in cancer clinical trials<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#07a52895d90ce8a89\">Madeline Pe<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#ec59c7651e67e0c0d\">Naomi Kiyota<\/a><\/td>\n<\/tr>\n<tr>\n<td>11:00 \u2013 11:10<\/td>\n<td>Introduction of session by Chairs<\/td>\n<\/tr>\n<tr>\n<td>11:10 \u2013 11:25<\/td>\n<td>SISAQOL-IMI and the estimand framework <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#de1906a34a768d71b\">Corneel Coens<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>11:25 \u2013 11:40<\/td>\n<td>Randomised controlled trials \u2013 example trial <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#800bc73157e8be809\">Antoine Regnault<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>11:40 \u2013 11:55<\/td>\n<td>Single arm studies \u2013 example trial <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#16fd4117a403bcd80\">Jammbe Musoro<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>11:55 \u2013 12:10<\/td>\n<td>Phase 1 and dose finding \u2013 example trial <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#dc1266b768e0525b3\">Christina Yap<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">12:10 \u2013 13:15<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Lunch break<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 8. Use of PROs for real world evidence generation and patient management<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#1d9df8d984231072b\">Anja Schiel<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#2299c6fea674c1a96\">Jaap Reijneveld<\/a><\/td>\n<\/tr>\n<tr>\n<td>13:15 &#8211; 13:25<\/td>\n<td>Introduction of session by Chairs<\/td>\n<\/tr>\n<tr>\n<td>13:25 \u2013 13:40<\/td>\n<td>The Cancer Care Ontario early adoption of PROs in clinical practice <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#b491b8fa7405ce223\">Michael Brundage<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>13:40 \u2013 13:55<\/td>\n<td>Symptom monitoring in daily clinical practice: Evidence gathered in the last 20 years <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#b12a907a35f30be83\">Galina Velikova<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>13:55 \u2013 14:10<\/td>\n<td>Implementation of PROs in daily clinical practice: Case study <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#4f84069198cc3a104\">August Zabernigg<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>14:10 \u2013 14:25<\/td>\n<td>Incorporation of PROs in registries <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#e0d844036f50efcad\">Lonneke van de Poll-Franse<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>14:25 &#8211; 14:40<\/td>\n<td>Implementing PROs in pragmatic precision medicine trials \u2013 lessons learned from the PRIME-ROSE community advisory board <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#20f5554795160aa04\">Bettina Ryll<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>14:40 &#8211; 14:55<\/td>\n<td>Collecting PROs as real world data <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#91168ca0e9ddcd358\">Erik Briers<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">14:55 \u2013 15:15<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Coffee break<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #c9ddff; color: #1f2f98;\" colspan=\"2\"><strong>SESSION 9. Electronic and digital outcome assessments<\/strong><br \/>\nChairs: <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#20f5554795160aa04\">Bettina Ryll<\/a> and <a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#e0d844036f50efcad\">Lonneke van de Poll-Franse<\/a><\/td>\n<\/tr>\n<tr>\n<td>15:15 &#8211; 15:25<\/td>\n<td>Introduction of session by Chairs<\/td>\n<\/tr>\n<tr>\n<td>15:25 \u2013 15:40<\/td>\n<td>Challenges in implementing PROs and digital health solutions in clinical trials led by industry <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#a3c5933803c0ec59d\">Paul O\u2019Donohoe<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>15:40 \u2013 15:55<\/td>\n<td>Challenges in implementing PRO and digital health solutions in clinical practice <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#93c548748cba7579b\">Bernhard Holzner<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>15:55 \u2013 16:10<\/td>\n<td>Consensus-developed eCOA resources and recommendations from the Critical Path Institute<em> (<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#14073907a67bc2710\">Scottie Kern<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td>16:10 \u2013 16:25<\/td>\n<td>Cutting edge research and academic view on PROs and digital health <em>(<a href=\"\/qol-conference-2025\/conference-speakers-chairs\/#6b4f75cf1dcea66da\">Katarzyna Wac<\/a>)<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: #f6f6f6;\">16:25 \u2013 16:45<\/td>\n<td style=\"background-color: #f6f6f6;\"><strong>Closing remarks and end of the conference<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div><\/div><\/div><div class=\"fusion-modal modal fade modal-1 contact-us\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"modal-heading-1\" aria-hidden=\"true\" style=\"--awb-border-color:rgba(255,255,255,0);--awb-background:rgba(206,231,232,0);\"><div class=\"modal-dialog modal-lg\" role=\"document\"><div class=\"modal-content fusion-modal-content\"><div class=\"modal-header\"><button class=\"close\" type=\"button\" data-dismiss=\"modal\" aria-hidden=\"true\" aria-label=\"Close\">&times;<\/button><h3 class=\"modal-title\" id=\"modal-heading-1\" data-dismiss=\"modal\" aria-hidden=\"true\"><\/h3><\/div><div class=\"modal-body fusion-clearfix\">\n<div class=\"fusion-form fusion-form-builder fusion-form-form-wrapper fusion-form-5800\" style=\"--awb-tooltip-text-color:var(--awb-color6);--awb-tooltip-background-color:var(--awb-custom_color_1);--awb-form-bg-color:var(--awb-custom_color_1);\" data-form-id=\"5800\" data-config=\"{&quot;form_id&quot;:&quot;5800&quot;,&quot;form_post_id&quot;:&quot;5800&quot;,&quot;post_id&quot;:5447,&quot;form_type&quot;:&quot;ajax&quot;,&quot;confirmation_type&quot;:&quot;message&quot;,&quot;redirect_url&quot;:&quot;&quot;,&quot;redirect_timeout&quot;:&quot;0&quot;,&quot;field_labels&quot;:{&quot;first_name&quot;:&quot;First name&quot;,&quot;last_name&quot;:&quot;Last name&quot;,&quot;email_address&quot;:&quot;Email address&quot;,&quot;your_message&quot;:&quot;Your message&quot;},&quot;field_logics&quot;:{&quot;first_name&quot;:&quot;&quot;,&quot;last_name&quot;:&quot;&quot;,&quot;email_address&quot;:&quot;&quot;,&quot;your_message&quot;:&quot;&quot;,&quot;submit_1&quot;:&quot;&quot;,&quot;notice_1&quot;:&quot;&quot;},&quot;field_types&quot;:{&quot;first_name&quot;:&quot;text&quot;,&quot;last_name&quot;:&quot;text&quot;,&quot;email_address&quot;:&quot;email&quot;,&quot;your_message&quot;:&quot;textarea&quot;,&quot;submit_1&quot;:&quot;submit&quot;,&quot;notice_1&quot;:&quot;notice&quot;},&quot;nonce_method&quot;:&quot;ajax&quot;,&quot;form_views&quot;:&quot;ajax&quot;,&quot;form_views_counting&quot;:&quot;all&quot;}\"><form action=\"https:\/\/event.eortc.org\/qol-conference-2025\/programme\/\" target=\"_self\" method=\"post\" class=\"fusion-form fusion-form-5800\"><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-right:20px;--awb-padding-left:20px;--awb-background-color:var(--awb-custom_color_1);--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_2 1_2 fusion-flex-column fusion-flex-align-self-stretch\" style=\"--awb-padding-top:20px;--awb-padding-left:40px;--awb-bg-size:cover;--awb-width-large:50%;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-margin-top-large:0px;--awb-spacing-right-large:3.84%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:3.84%;--awb-width-medium:50%;--awb-order-medium:0;--awb-flex-grow-medium:;--awb-flex-shrink-medium:;--awb-spacing-right-medium:3.84%;--awb-spacing-left-medium:3.84%;--awb-width-small:100%;--awb-order-small:0;--awb-flex-grow-small:;--awb-flex-shrink-small:;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color4);--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-font-size:60px;\"><h2 class=\"fusion-title-heading title-heading-left\" style=\"margin:0;font-size:1em;\">Contact us<\/h2><\/div><div class=\"fusion-text fusion-text-1\" style=\"--awb-text-color:var(--awb-color6);\"><div><strong style=\"font-size: 24px;\" data-fusion-font=\"true\">EORTC QOL Conference Secretariat<\/strong><\/div>\n<div style=\"margin-top: 15px;\">C\/O EORTC<\/div>\n<div>Avenue E. Mounier 83<br \/>\nB-1200 Brussels, Belgium<\/div>\n<\/div>\n<\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_2 1_2 fusion-flex-column\" style=\"--awb-padding-top:25px;--awb-bg-size:cover;--awb-width-large:50%;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-margin-top-large:0px;--awb-spacing-right-large:3.84%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:3.84%;--awb-width-medium:50%;--awb-order-medium:0;--awb-flex-grow-medium:;--awb-flex-shrink-medium:;--awb-spacing-right-medium:3.84%;--awb-spacing-left-medium:3.84%;--awb-width-small:100%;--awb-order-small:0;--awb-flex-grow-small:;--awb-flex-shrink-small:;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-form-field fusion-form-text-field fusion-form-label-above\" style=\"\" data-form-id=\"5800\"><div class=\"fusion-form-label-wrapper\"><label for=\"first_name\">First name<\/label><\/div><input type=\"text\" autocomplete=\"off\" name=\"first_name\" id=\"first_name\" value=\"\"  class=\"fusion-form-input\" data-holds-private-data=\"false\" minlength=\"0\"\/><\/div><div class=\"fusion-form-field fusion-form-text-field fusion-form-label-above\" style=\"\" data-form-id=\"5800\"><div class=\"fusion-form-label-wrapper\"><label for=\"last_name\">Last name<\/label><\/div><input type=\"text\" autocomplete=\"off\" name=\"last_name\" id=\"last_name\" value=\"\"  class=\"fusion-form-input\" data-holds-private-data=\"false\" minlength=\"0\"\/><\/div><div class=\"fusion-form-field fusion-form-email-field fusion-form-label-above\" style=\"\" data-form-id=\"5800\"><div class=\"fusion-form-label-wrapper\"><label for=\"email_address\">Email address<\/label><\/div><input type=\"email\" autocomplete=\"off\" name=\"email_address\" id=\"email_address\" value=\"\"  class=\"fusion-form-input\" data-holds-private-data=\"false\"\/><\/div><div class=\"fusion-form-field fusion-form-textarea-field fusion-form-label-above\" style=\"\" data-form-id=\"5800\"><label for=\"your_message\">Your message<\/label><textarea cols=\"40\" autocomplete=\"off\"  minlength=\"0\"  rows=\"4\" tabindex=\"\" id=\"your_message\" name=\"your_message\" class=\"fusion-form-input\" data-holds-private-data=\"false\"><\/textarea><\/div><div class=\"fusion-form-field fusion-form-submit-field fusion-form-label-above\" style=\"\" data-form-id=\"5800\"><div ><button type=\"submit\" class=\"fusion-button button-flat fusion-button-default-size button-default fusion-button-default button-1 fusion-button-default-span  button-default form-form-submit\" data-form-number=\"5800\" tabindex=\"\"><span class=\"fusion-button-text awb-button__text awb-button__text--default\">Send message<\/span><\/button><\/div><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-flex-grow-medium:;--awb-flex-shrink-medium:;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-flex-grow-small:;--awb-flex-shrink-small:;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"form-submission-notices data-notice_1\" id=\"fusion-notices-1\" data-instance=\"1\"><div class=\"fusion-alert alert success alert-success fusion-alert-center fusion-form-response fusion-form-response-success awb-alert-native-link-color alert-dismissable awb-alert-close-boxed\" role=\"alert\"><div class=\"fusion-alert-content-wrapper\"><span class=\"alert-icon\"><i class=\"awb-icon-check-circle\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-alert-content\">Thank you for your message. It has been sent.<\/span><\/div><button type=\"button\" class=\"close toggle-alert\" data-dismiss=\"alert\" aria-label=\"Close\">&times;<\/button><\/div><div class=\"fusion-alert alert error alert-danger fusion-alert-center fusion-form-response fusion-form-response-error awb-alert-native-link-color alert-dismissable awb-alert-close-boxed\" role=\"alert\"><div class=\"fusion-alert-content-wrapper\"><span class=\"alert-icon\"><i class=\"awb-icon-exclamation-triangle\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-alert-content\">There was an error trying to send your message. Please try again later.<\/span><\/div><button type=\"button\" class=\"close toggle-alert\" data-dismiss=\"alert\" aria-label=\"Close\">&times;<\/button><\/div><\/div><\/div><\/div><\/div><\/div><\/form><\/div>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-5447","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/event.eortc.org\/qol-conference-2025\/wp-json\/wp\/v2\/pages\/5447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/event.eortc.org\/qol-conference-2025\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/event.eortc.org\/qol-conference-2025\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/event.eortc.org\/qol-conference-2025\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/event.eortc.org\/qol-conference-2025\/wp-json\/wp\/v2\/comments?post=5447"}],"version-history":[{"count":0,"href":"https:\/\/event.eortc.org\/qol-conference-2025\/wp-json\/wp\/v2\/pages\/5447\/revisions"}],"wp:attachment":[{"href":"https:\/\/event.eortc.org\/qol-conference-2025\/wp-json\/wp\/v2\/media?parent=5447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}